US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organon & Co

10.63

+0.17501.67%

Volume:2.45M

Turnover:25.87M

Market Cap:2.76B

PE:3.95

High:10.70

Open:10.43

Low:10.33

Close:10.45

52wk High:20.09

52wk Low:8.01

Shares:259.97M

Float Shares:258.73M

Volume Ratio:0.47

T/O Rate:0.95%

Dividend:0.60

Dividend Rate:5.65%

EPS(TTM):2.69

EPS(LYR):3.36

ROE:159.64%

ROA:6.62%

PB:3.77

PE(LYR):3.16

Loading ...

Overview Company News Filings

Organon's VTAMA Cream Receives Strong Recommendation in Updated 2025 AAD Guidelines for Adult Atopic Dermatitis

Karolinska Development Faces Impairment Following Organon's Discontinuation of OG-6219

Organon & Co. Files Initial Beneficial Ownership Statement for Director Ramona Sequeira

BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial

BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier

Organon to halt development of pelvic pain drug after mid-stage trial failure

Organon & Co. Discontinues Development of Endometriosis Drug After Phase 2 Study Fails Primary Efficacy Endpoint

Shanghai Henlius Biotech Inc. Obtains EU GMP Certificates for HLX11 and HLX14 Production Lines

Organon & Co. Faces Securities Class Action Lawsuit Over Dividend Misrepresentation; Shareholder Deadline Approaches

Organon & Co. Conducted Annual Shareholder Meeting

Securities Fraud Lawsuit Filed Against Organon & Co. Over Dividend and Debt Allocation Post-Dermavant Acquisition

Press Release: Shareholders who lost money on Organon & Co. (NYSE: OGN) Should Contact Wolf Haldenstein

Organon & Co. Faces Securities Fraud Lawsuit Over Alleged Misleading Capital Allocation Priorities

Organon, Samsung Bioepis Say FDA Grants Interchangeability Designation to Hadlima

MT Newswires Live

Organon & Co. Files Initial Beneficial Ownership Statement for Lynette Holzbaur, SVP and Corporate Controller

Organon & Is Maintained at Overweight by Piper Sandler

BRIEF-EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets

EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug

BUZZ-U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, Skechers

Evercore ISI Downgrades Organon to In Line From Outperform

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OGN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGN\",,,,,undefined,":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":10.625,"timestamp":1758570562980,"preClose":10.45,"halted":0,"volume":2446233,"delay":0,"floatShares":258733290,"shares":259965579,"eps":2.687973,"marketStatus":"Trading","change":0.175,"latestTime":"09-22 15:49:23 EDT","open":10.43,"high":10.7,"low":10.3324,"amount":25871482.51965,"amplitude":0.035177,"askPrice":10.63,"askSize":464,"bidPrice":10.62,"bidSize":2300,"shortable":3,"etf":0,"ttmEps":2.687973,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1758571200000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":10.45,"dividendRate":0.056471,"preHourTrading":{"tag":"盘前","latestPrice":10.45,"preClose":10.45,"latestTime":"08:49 EDT","volume":982,"amount":10264.179221999999,"timestamp":1758545367979},"postHourTrading":{"tag":"盘后","latestPrice":10.45,"preClose":10.45,"latestTime":"19:45 EDT","volume":2145832,"amount":22423963.738116,"timestamp":1758325526950},"volumeRatio":0.474061,"impliedVol":0.2889,"impliedVolPercentile":0.028},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGN\",,,,,undefined,":{"symbol":"OGN","floatShares":258733290,"roa":"6.62%","roe":"159.64%","lyrEps":3.361266,"volumeRatio":0.474061,"shares":259965579,"dividePrice":0.6,"high":10.7,"amplitude":0.035177,"preClose":10.45,"low":10.3324,"week52Low":8.01,"pbRate":"3.77","psRate":"0.44","week52High":20.09,"institutionHeld":0,"latestPrice":10.625,"committee":0.664255,"eps":2.687973,"divideRate":0.056471,"volume":2446233,"delay":0,"ttmEps":2.687973,"open":10.43,"prevYearClose":14.92,"prevWeekClose":10.45,"prevMonthClose":9.42,"prevQuarterClose":9.68,"fiveDayClose":10.4,"twentyDayClose":9.43,"sixtyDayClose":9.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OGN\",params:#limit:5,,,undefined,":[{"date":"2025-08-15","symbol":"OGN","amount":0.02,"announcedDate":"2025-08-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-11","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-09-11"},{"market":"US","date":"2025-08-05","symbol":"OGN","fiscalQuarterEnding":"2025/06","expectedEps":0.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":0.94},{"date":"2025-05-12","symbol":"OGN","amount":0.02,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-12","defaultRemindTime":1747056600000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-12","currency":"USD","dateTimestamp":1747022400000,"payDate":"2025-06-12"},{"market":"US","date":"2025-05-01","symbol":"OGN","fiscalQuarterEnding":"2025/03","expectedEps":0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":0.95},{"date":"2025-02-24","symbol":"OGN","amount":0.28,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-24","defaultRemindTime":1740407400000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-13","payableDate":"2025-02-24","currency":"USD","dateTimestamp":1740373200000,"payDate":"2025-03-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OGN\",market:\"US\",,,undefined,":[{"executeDate":"2021-08-20","recordDate":"2021-08-23","paymentDate":"2021-09-13","value":0.28,"currency":"USD"},{"executeDate":"2021-11-19","recordDate":"2021-11-22","paymentDate":"2021-12-16","value":0.28,"currency":"USD"},{"executeDate":"2022-02-25","recordDate":"2022-02-28","paymentDate":"2022-03-17","value":0.28,"currency":"USD"},{"executeDate":"2022-05-13","recordDate":"2022-05-16","paymentDate":"2022-06-16","value":0.28,"currency":"USD"},{"executeDate":"2022-08-12","recordDate":"2022-08-15","paymentDate":"2022-09-15","value":0.28,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.375,"sell":0.375,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.375,"analysts":8,"updateTime":1754452800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OGN","date":"2025-09-19","current":4.029466,"percent":0.19334,"low":2.786729,"twenty":4.045602,"median":5.247806,"eighty":6.786941,"high":8.287792,"avg":5.370102,"sd":1.379206,"marketCap":2820626532},"quantilePoints":[{"date":"2021-05-14","current":3.896567,"twenty":3.896567,"median":3.896567,"eighty":3.896567,"marketCap":8416584968},{"date":"2021-05-21","current":4.406344,"twenty":3.996179,"median":4.394625,"eighty":4.406344,"marketCap":9517702100},{"date":"2021-05-28","current":4.189542,"twenty":4.160245,"median":4.33017,"eighty":4.406344,"marketCap":9049410906},{"date":"2021-06-04","current":4.002038,"twenty":4.106103,"median":4.316107,"eighty":4.396969,"marketCap":8644402306},{"date":"2021-06-11","current":3.474683,"twenty":3.656562,"median":4.174893,"eighty":4.394625,"marketCap":7505315618},{"date":"2021-06-18","current":3.513356,"twenty":3.5532,"median":4.002038,"eighty":4.347749,"marketCap":7588848642},{"date":"2021-06-25","current":4.123733,"twenty":3.589061,"median":4.031533,"eighty":4.331342,"marketCap":7653648040},{"date":"2021-07-02","current":4.21525,"twenty":3.665234,"median":4.123733,"eighty":4.31892,"marketCap":7823503760},{"date":"2021-07-09","current":4.111439,"twenty":3.684922,"median":4.114171,"eighty":4.267067,"marketCap":7630831600},{"date":"2021-07-16","current":3.94343,"twenty":3.711407,"median":4.064315,"eighty":4.229455,"marketCap":7319006920},{"date":"2021-07-23","current":4.070462,"twenty":3.829066,"median":4.066364,"eighty":4.224538,"marketCap":7554776800},{"date":"2021-07-30","current":3.962553,"twenty":3.924685,"median":4.056802,"eighty":4.220682,"marketCap":7354499160},{"date":"2021-08-06","current":4.029484,"twenty":3.930317,"median":4.044509,"eighty":4.216686,"marketCap":7478722000},{"date":"2021-08-13","current":4.981495,"twenty":3.946708,"median":4.050656,"eighty":4.220682,"marketCap":8672782360},{"date":"2021-08-20","current":4.83789,"twenty":3.957089,"median":4.062266,"eighty":4.321732,"marketCap":8422766594},{"date":"2021-08-27","current":4.987891,"twenty":3.969929,"median":4.07934,"eighty":4.399313,"marketCap":8683917996},{"date":"2021-09-03","current":5.18595,"twenty":3.974847,"median":4.114171,"eighty":4.832647,"marketCap":9028739266},{"date":"2021-09-10","current":4.934007,"twenty":3.97594,"median":4.132119,"eighty":4.866681,"marketCap":8590106327},{"date":"2021-09-17","current":4.955852,"twenty":3.978671,"median":4.152916,"eighty":4.910706,"marketCap":8628138085},{"date":"2021-09-24","current":4.906337,"twenty":3.985228,"median":4.172906,"eighty":4.908958,"marketCap":8541932768},{"date":"2021-10-01","current":4.85391,"twenty":3.994034,"median":4.212518,"eighty":4.908958,"marketCap":8450656549},{"date":"2021-10-08","current":4.743229,"twenty":3.998523,"median":4.223445,"eighty":4.900512,"marketCap":8257962311},{"date":"2021-10-15","current":5.081095,"twenty":4.004274,"median":4.27524,"eighty":4.903424,"marketCap":8846186829},{"date":"2021-10-22","current":5.193232,"twenty":4.011453,"median":4.33603,"eighty":4.922647,"marketCap":9041416518},{"date":"2021-10-29","current":5.35197,"twenty":4.022108,"median":4.400484,"eighty":4.947405,"marketCap":9317780624},{"date":"2021-11-05","current":5.283524,"twenty":4.029484,"median":4.45322,"eighty":4.985333,"marketCap":9198614450},{"date":"2021-11-12","current":5.632588,"twenty":4.03003,"median":4.749054,"eighty":5.060998,"marketCap":8544635977},{"date":"2021-11-19","current":5.223097,"twenty":4.031943,"median":4.78255,"eighty":5.132066,"marketCap":7923438406},{"date":"2021-11-26","current":5.20304,"twenty":4.033582,"median":4.789832,"eighty":5.18595,"marketCap":7893012402},{"date":"2021-12-03","current":4.818621,"twenty":4.034401,"median":4.79951,"eighty":5.179251,"marketCap":7309847336},{"date":"2021-12-10","current":4.803578,"twenty":4.039045,"median":4.803578,"eighty":5.151872,"marketCap":7287027833},{"date":"2021-12-17","current":5.04593,"twenty":4.045602,"median":4.817333,"eighty":5.143194,"marketCap":7654675375},{"date":"2021-12-23","current":5.050944,"twenty":4.049973,"median":4.823635,"eighty":5.1178,"marketCap":7662281876},{"date":"2021-12-31","current":5.089386,"twenty":4.051339,"median":4.829152,"eighty":5.1178,"marketCap":7720598383},{"date":"2022-01-07","current":5.416979,"twenty":4.062266,"median":4.839346,"eighty":5.18595,"marketCap":8217556439},{"date":"2022-01-14","current":5.492191,"twenty":4.062266,"median":4.85391,"eighty":5.198026,"marketCap":8331653952},{"date":"2022-01-21","current":5.176298,"twenty":4.065544,"median":4.867016,"eighty":5.203991,"marketCap":7852444398},{"date":"2022-01-28","current":5.256525,"twenty":4.069642,"median":4.884984,"eighty":5.203991,"marketCap":7974148412},{"date":"2022-02-04","current":5.535647,"twenty":4.084668,"median":4.898847,"eighty":5.229783,"marketCap":8397576960},{"date":"2022-02-11","current":5.80307,"twenty":4.106795,"median":4.900622,"eighty":5.273377,"marketCap":8803257006},{"date":"2022-02-18","current":6.77322,"twenty":4.113625,"median":4.906337,"eighty":5.293446,"marketCap":9150620546},{"date":"2022-02-25","current":7.05098,"twenty":4.119908,"median":4.910706,"eighty":5.324449,"marketCap":9525874589},{"date":"2022-03-04","current":7.285575,"twenty":4.128765,"median":4.921628,"eighty":5.348475,"marketCap":9842812125},{"date":"2022-03-11","current":6.724425,"twenty":4.132824,"median":4.935463,"eighty":5.378584,"marketCap":9084697539},{"date":"2022-03-18","current":6.583668,"twenty":4.14067,"median":4.952211,"eighty":5.411178,"marketCap":8894535017},{"date":"2022-03-25","current":6.569034,"twenty":4.154382,"median":4.966046,"eighty":5.494865,"marketCap":8874764893},{"date":"2022-04-01","current":6.599072,"twenty":4.160466,"median":4.982791,"eighty":5.52261,"marketCap":8915346841},{"date":"2022-04-08","current":6.734245,"twenty":4.167989,"median":4.995788,"eighty":5.60384,"marketCap":9097965610},{"date":"2022-04-14","current":6.552137,"twenty":4.17956,"median":5.015845,"eighty":5.704124,"marketCap":8851937547},{"date":"2022-04-22","current":6.056503,"twenty":4.19764,"median":5.039484,"eighty":5.803024,"marketCap":8182335394},{"date":"2022-04-29","current":6.069645,"twenty":4.211972,"median":5.050944,"eighty":6.058632,"marketCap":8200089997},{"date":"2022-05-06","current":6.783819,"twenty":4.216686,"median":5.075212,"eighty":6.073577,"marketCap":8818964713},{"date":"2022-05-13","current":6.816987,"twenty":4.220682,"median":5.089386,"eighty":6.132725,"marketCap":8862083034},{"date":"2022-05-20","current":7.343772,"twenty":4.224538,"median":5.111826,"eighty":6.249124,"marketCap":9546903417},{"date":"2022-05-27","current":7.589605,"twenty":4.229455,"median":5.132842,"eighty":6.481977,"marketCap":9866486263},{"date":"2022-06-03","current":7.254023,"twenty":4.25072,"median":5.136185,"eighty":6.547256,"marketCap":9430230315},{"date":"2022-06-10","current":6.918442,"twenty":4.31892,"median":5.164376,"eighty":6.569034,"marketCap":8993974367},{"date":"2022-06-17","current":6.47165,"twenty":4.331342,"median":5.18595,"eighty":6.569034,"marketCap":8413145227},{"date":"2022-06-24","current":6.996484,"twenty":4.33603,"median":5.193232,"eighty":6.583668,"marketCap":9095429238},{"date":"2022-07-01","current":6.682364,"twenty":4.394625,"median":5.202505,"eighty":6.604705,"marketCap":8687073380},{"date":"2022-07-08","current":6.389706,"twenty":4.394625,"median":5.207925,"eighty":6.609211,"marketCap":8306617612},{"date":"2022-07-15","current":6.237524,"twenty":4.404,"median":5.223097,"eighty":6.603203,"marketCap":8108780612},{"date":"2022-07-22","current":6.235572,"twenty":4.420406,"median":5.267389,"eighty":6.599823,"marketCap":8106244240},{"date":"2022-07-29","current":6.188747,"twenty":4.44736,"median":5.280611,"eighty":6.587663,"marketCap":8045371317},{"date":"2022-08-05","current":7.237028,"twenty":4.680567,"median":5.285902,"eighty":6.599823,"marketCap":8011390369},{"date":"2022-08-12","current":7.119857,"twenty":4.742064,"median":5.318366,"eighty":6.631739,"marketCap":7881682144},{"date":"2022-08-19","current":7.044041,"twenty":4.75255,"median":5.333952,"eighty":6.664515,"marketCap":7797753292},{"date":"2022-08-26","current":6.821186,"twenty":4.77119,"median":5.346145,"eighty":6.72327,"marketCap":7551053335},{"date":"2022-09-02","current":6.547788,"twenty":4.781094,"median":5.361158,"eighty":6.72327,"marketCap":7248400810},{"date":"2022-09-09","current":6.853351,"twenty":4.78255,"median":5.379411,"eighty":6.728353,"marketCap":7586659514},{"date":"2022-09-16","current":6.57306,"twenty":4.786919,"median":5.388565,"eighty":6.728353,"marketCap":7276377094},{"date":"2022-09-23","current":5.915983,"twenty":4.79106,"median":5.433693,"eighty":6.723559,"marketCap":6548993714},{"date":"2022-09-30","current":5.376078,"twenty":4.795019,"median":5.450406,"eighty":6.698611,"marketCap":5951318560},{"date":"2022-10-07","current":5.516224,"twenty":4.797113,"median":5.495534,"eighty":6.676511,"marketCap":6106459770},{"date":"2022-10-14","current":5.355401,"twenty":4.799989,"median":5.473806,"eighty":6.672609,"marketCap":5928428873},{"date":"2022-10-21","current":5.440407,"twenty":4.80291,"median":5.469126,"eighty":6.666539,"marketCap":6022530919},{"date":"2022-10-28","current":6.014775,"twenty":4.808437,"median":5.492191,"eighty":6.657079,"marketCap":6658355551},{"date":"2022-11-04","current":6.126383,"twenty":4.814297,"median":5.504727,"eighty":6.648993,"marketCap":6193773359},{"date":"2022-11-11","current":6.367916,"twenty":4.817591,"median":5.516224,"eighty":6.640375,"marketCap":6437963191},{"date":"2022-11-18","current":6.138963,"twenty":4.820626,"median":5.526562,"eighty":6.635494,"marketCap":6206491579},{"date":"2022-11-25","current":6.317597,"twenty":4.8233,"median":5.544315,"eighty":6.633241,"marketCap":6387090309},{"date":"2022-12-02","current":6.722668,"twenty":4.826262,"median":5.573661,"eighty":6.635869,"marketCap":6796617008},{"date":"2022-12-09","current":6.805695,"twenty":4.828278,"median":5.604174,"eighty":6.642253,"marketCap":6880557263},{"date":"2022-12-16","current":6.903817,"twenty":4.832065,"median":5.632588,"eighty":6.668562,"marketCap":6979759382},{"date":"2022-12-23","current":7.0271,"twenty":4.837016,"median":5.685088,"eighty":6.722856,"marketCap":7104397943},{"date":"2022-12-30","current":7.0271,"twenty":4.838473,"median":5.752092,"eighty":6.741307,"marketCap":7104397943},{"date":"2023-01-06","current":7.334048,"twenty":4.840803,"median":5.779739,"eighty":6.752576,"marketCap":7414722522},{"date":"2023-01-13","current":8.066195,"twenty":4.849541,"median":5.80307,"eighty":6.76196,"marketCap":8154922952},{"date":"2023-01-20","current":7.885045,"twenty":4.853036,"median":5.886639,"eighty":6.782258,"marketCap":7971780578},{"date":"2023-01-27","current":7.53281,"twenty":4.859735,"median":5.911388,"eighty":6.797626,"marketCap":7615670405},{"date":"2023-02-03","current":7.487522,"twenty":4.865851,"median":5.943859,"eighty":6.817827,"marketCap":7569884811},{"date":"2023-02-10","current":7.30134,"twenty":4.87589,"median":5.981259,"eighty":6.844798,"marketCap":7381655149},{"date":"2023-02-17","current":7.217625,"twenty":4.883215,"median":6.014775,"eighty":6.899163,"marketCap":6618561922},{"date":"2023-02-24","current":7.098348,"twenty":4.885082,"median":6.02271,"eighty":6.906249,"marketCap":6509185226},{"date":"2023-03-03","current":6.81313,"twenty":4.889255,"median":6.048275,"eighty":6.906249,"marketCap":6247639897},{"date":"2023-03-10","current":6.291603,"twenty":4.896018,"median":6.063022,"eighty":6.904767,"marketCap":5769400361},{"date":"2023-03-17","current":6.011422,"twenty":4.898847,"median":6.061537,"eighty":6.902307,"marketCap":5512473802},{"date":"2023-03-24","current":6.064129,"twenty":4.898972,"median":6.063022,"eighty":6.899698,"marketCap":5560806521},{"date":"2023-03-31","current":6.524626,"twenty":4.900936,"median":6.071417,"eighty":6.886443,"marketCap":5983081856},{"date":"2023-04-06","current":6.557915,"twenty":4.90219,"median":6.080188,"eighty":6.876603,"marketCap":6013607784},{"date":"2023-04-14","current":6.652233,"twenty":4.903849,"median":6.089096,"eighty":6.865757,"marketCap":6100097913},{"date":"2023-04-21","current":6.571785,"twenty":4.906684,"median":6.114299,"eighty":6.849075,"marketCap":6026326921},{"date":"2023-04-28","current":6.767337,"twenty":4.908605,"median":6.136447,"eighty":6.835908,"marketCap":6205648387},{"date":"2023-05-05","current":7.525343,"twenty":4.910706,"median":6.154734,"eighty":6.852323,"marketCap":5613905507},{"date":"2023-05-12","current":7.231308,"twenty":4.913036,"median":6.169544,"eighty":6.900232,"marketCap":5394555949},{"date":"2023-05-19","current":6.998812,"twenty":4.920609,"median":6.176067,"eighty":6.910087,"marketCap":5221113961},{"date":"2023-05-26","current":6.79025,"twenty":4.929638,"median":6.195431,"eighty":6.916101,"marketCap":5065526295},{"date":"2023-06-02","current":6.650068,"twenty":4.934298,"median":6.198502,"eighty":6.912589,"marketCap":4960950979},{"date":"2023-06-09","current":6.841536,"twenty":4.937502,"median":6.209295,"eighty":6.912589,"marketCap":5103785557},{"date":"2023-06-16","current":7.15267,"twenty":4.94624,"median":6.214111,"eighty":6.938687,"marketCap":5335891747},{"date":"2023-06-23","current":7.149251,"twenty":4.94857,"median":6.219474,"eighty":6.960156,"marketCap":5333341129},{"date":"2023-06-30","current":7.087708,"twenty":4.954396,"median":6.23457,"eighty":6.972651,"marketCap":5287430015},{"date":"2023-07-07","current":6.810764,"twenty":4.957751,"median":6.237524,"eighty":6.979666,"marketCap":5080830000},{"date":"2023-07-14","current":7.08087,"twenty":4.963234,"median":6.25344,"eighty":6.981717,"marketCap":5282328780},{"date":"2023-07-21","current":7.145832,"twenty":4.973863,"median":6.266772,"eighty":6.993719,"marketCap":5330790512},{"date":"2023-07-28","current":7.480899,"twenty":4.980527,"median":6.283214,"eighty":7.009926,"marketCap":5580751024},{"date":"2023-08-04","current":7.354394,"twenty":4.983051,"median":6.298006,"eighty":7.022062,"marketCap":5486378177},{"date":"2023-08-11","current":8.00261,"twenty":4.98637,"median":6.34288,"eighty":7.029904,"marketCap":6033968058},{"date":"2023-08-18","current":7.606039,"twenty":4.992629,"median":6.368244,"eighty":7.03947,"marketCap":5734953123},{"date":"2023-08-25","current":7.32471,"twenty":4.99804,"median":6.384829,"eighty":7.061003,"marketCap":5522831416},{"date":"2023-09-01","current":7.443343,"twenty":5.009323,"median":6.401412,"eighty":7.09045,"marketCap":5612280329},{"date":"2023-09-08","current":6.599357,"twenty":5.018519,"median":6.403954,"eighty":7.092056,"marketCap":4975915209},{"date":"2023-09-15","current":6.707821,"twenty":5.029216,"median":6.413118,"eighty":7.091127,"marketCap":5057697072},{"date":"2023-09-22","current":6.297692,"twenty":5.033037,"median":6.41507,"eighty":7.089999,"marketCap":4748459404},{"date":"2023-09-27","current":5.846888,"twenty":5.040773,"median":6.412051,"eighty":7.088624,"marketCap":4408553537},{"date":"2023-10-06","current":5.497769,"twenty":5.04868,"median":6.402566,"eighty":7.083605,"marketCap":4145318166},{"date":"2023-10-13","current":5.640128,"twenty":5.050772,"median":6.394583,"eighty":7.069742,"marketCap":4252656861},{"date":"2023-10-20","current":5.470653,"twenty":5.06117,"median":6.373784,"eighty":7.061003,"marketCap":4124872700},{"date":"2023-10-27","current":5.189325,"twenty":5.067988,"median":6.368244,"eighty":7.060123,"marketCap":3912750994},{"date":"2023-11-03","current":5.727352,"twenty":5.066495,"median":6.367916,"eighty":7.054838,"marketCap":3350500688},{"date":"2023-11-10","current":4.989788,"twenty":5.066495,"median":6.324385,"eighty":7.051487,"marketCap":2919025784},{"date":"2023-11-17","current":4.784429,"twenty":5.049596,"median":6.297692,"eighty":7.045429,"marketCap":2798890747},{"date":"2023-11-24","current":4.963572,"twenty":5.023868,"median":6.291603,"eighty":7.03947,"marketCap":2903689396},{"date":"2023-12-01","current":4.946094,"twenty":4.995136,"median":6.269431,"eighty":7.034371,"marketCap":2893465138},{"date":"2023-12-08","current":4.950464,"twenty":4.989029,"median":6.259729,"eighty":7.033003,"marketCap":2896021203},{"date":"2023-12-15","current":5.601495,"twenty":4.986902,"median":6.239821,"eighty":7.031403,"marketCap":3276874830},{"date":"2023-12-22","current":5.942304,"twenty":4.989029,"median":6.23457,"eighty":7.029904,"marketCap":3476247869},{"date":"2023-12-29","current":6.326806,"twenty":4.990662,"median":6.232836,"eighty":7.029113,"marketCap":3701181555},{"date":"2024-01-05","current":6.020952,"twenty":4.993283,"median":6.23457,"eighty":7.027603,"marketCap":3522257032},{"date":"2024-01-12","current":7.353601,"twenty":4.995462,"median":6.239821,"eighty":7.033003,"marketCap":4301856738},{"date":"2024-01-19","current":6.855496,"twenty":4.99804,"median":6.25344,"eighty":7.034371,"marketCap":4010465373},{"date":"2024-01-26","current":7.357971,"twenty":5.004175,"median":6.266772,"eighty":7.046817,"marketCap":4304412803},{"date":"2024-02-02","current":7.532744,"twenty":5.012413,"median":6.283214,"eighty":7.068727,"marketCap":4406655387},{"date":"2024-02-09","current":7.126396,"twenty":5.021183,"median":6.296221,"eighty":7.088624,"marketCap":4168941378},{"date":"2024-02-16","current":4.652387,"twenty":5.012413,"median":6.296957,"eighty":7.09045,"marketCap":4759392303},{"date":"2024-02-23","current":4.634897,"twenty":4.994809,"median":6.291603,"eighty":7.089083,"marketCap":4741499851},{"date":"2024-03-01","current":4.350598,"twenty":4.98462,"median":6.272091,"eighty":7.084973,"marketCap":4450662036},{"date":"2024-03-08","current":4.555509,"twenty":4.964562,"median":6.260435,"eighty":7.079855,"marketCap":4660285406},{"date":"2024-03-15","current":4.587995,"twenty":4.952619,"median":6.242118,"eighty":7.071929,"marketCap":4693518380},{"date":"2024-03-22","current":4.573001,"twenty":4.943298,"median":6.235071,"eighty":7.061443,"marketCap":4678180084},{"date":"2024-03-28","current":4.610485,"twenty":4.934298,"median":6.225288,"eighty":7.058802,"marketCap":4716525823},{"date":"2024-04-05","current":4.465548,"twenty":4.910706,"median":6.214111,"eighty":7.05301,"marketCap":4568255634},{"date":"2024-04-12","current":4.568003,"twenty":4.903019,"median":6.209295,"eighty":7.049592,"marketCap":4673067319},{"date":"2024-04-19","current":4.463049,"twenty":4.898847,"median":6.198502,"eighty":7.043908,"marketCap":4565699252},{"date":"2024-04-26","current":4.630616,"twenty":4.884689,"median":6.192329,"eighty":7.041987,"marketCap":4737120415},{"date":"2024-05-03","current":4.789749,"twenty":4.859204,"median":6.177041,"eighty":7.035738,"marketCap":5014866889},{"date":"2024-05-10","current":5.037795,"twenty":4.859204,"median":6.174207,"eighty":7.033003,"marketCap":5274571610},{"date":"2024-05-17","current":5.285878,"twenty":4.862356,"median":6.159481,"eighty":7.03247,"marketCap":5534314045},{"date":"2024-05-24","current":5.244121,"twenty":4.869234,"median":6.145607,"eighty":7.030192,"marketCap":5490595021},{"date":"2024-05-31","current":5.239209,"twenty":4.878108,"median":6.131415,"eighty":7.029616,"marketCap":5485451606},{"date":"2024-06-07","current":5.096746,"twenty":4.884492,"median":6.103438,"eighty":7.0271,"marketCap":5336292585},{"date":"2024-06-14","current":5.010776,"twenty":4.885476,"median":6.088194,"eighty":7.0271,"marketCap":5246282830},{"date":"2024-06-21","current":5.118852,"twenty":4.88853,"median":6.082147,"eighty":7.026352,"marketCap":5359437950},{"date":"2024-06-28","current":5.084464,"twenty":4.891278,"median":6.073189,"eighty":7.020695,"marketCap":5323434048},{"date":"2024-07-05","current":4.939545,"twenty":4.896018,"median":6.064129,"eighty":7.017328,"marketCap":5171703319},{"date":"2024-07-12","current":5.23184,"twenty":4.89435,"median":6.06089,"eighty":7.015943,"marketCap":5477736485},{"date":"2024-07-19","current":5.15324,"twenty":4.897441,"median":6.056503,"eighty":7.015908,"marketCap":5395441852},{"date":"2024-07-26","current":5.450447,"twenty":4.898847,"median":6.031808,"eighty":7.011417,"marketCap":5706618432},{"date":"2024-08-02","current":5.136046,"twenty":4.898972,"median":6.020952,"eighty":7.006932,"marketCap":5377439901},{"date":"2024-08-09","current":5.188091,"twenty":4.898972,"median":6.014775,"eighty":7.001662,"marketCap":5188090561},{"date":"2024-08-16","current":5.239585,"twenty":4.900936,"median":6.000585,"eighty":6.998812,"marketCap":5239585256},{"date":"2024-08-23","current":5.757107,"twenty":4.90219,"median":5.959636,"eighty":6.997415,"marketCap":5757106945},{"date":"2024-08-30","current":5.754532,"twenty":4.903798,"median":5.942304,"eighty":6.993719,"marketCap":5754532210},{"date":"2024-09-06","current":5.275632,"twenty":4.905457,"median":5.929614,"eighty":6.98918,"marketCap":5275631543},{"date":"2024-09-13","current":5.270482,"twenty":4.90651,"median":5.911666,"eighty":6.983768,"marketCap":5270482074},{"date":"2024-09-20","current":5.018158,"twenty":4.906944,"median":5.888414,"eighty":6.981717,"marketCap":5018158066},{"date":"2024-09-27","current":4.938341,"twenty":4.906944,"median":5.877393,"eighty":6.980349,"marketCap":4938341288},{"date":"2024-10-04","current":4.70919,"twenty":4.903262,"median":5.846888,"eighty":6.977944,"marketCap":4709189894},{"date":"2024-10-11","current":4.634523,"twenty":4.89893,"median":5.810762,"eighty":6.975032,"marketCap":4634522586},{"date":"2024-10-18","current":4.534108,"twenty":4.892215,"median":5.802956,"eighty":6.971085,"marketCap":4534107929},{"date":"2024-10-25","current":4.418245,"twenty":4.880662,"median":5.779739,"eighty":6.96953,"marketCap":4418244865},{"date":"2024-11-01","current":3.577039,"twenty":4.855829,"median":5.757942,"eighty":6.964887,"marketCap":4653727471},{"date":"2024-11-08","current":3.175191,"twenty":4.842721,"median":5.751562,"eighty":6.958755,"marketCap":4130923555},{"date":"2024-11-15","current":2.975257,"twenty":4.828278,"median":5.744233,"eighty":6.955647,"marketCap":3870809291},{"date":"2024-11-22","current":3.024746,"twenty":4.819383,"median":5.729964,"eighty":6.951383,"marketCap":3935194010},{"date":"2024-11-29","current":3.141539,"twenty":4.816182,"median":5.718079,"eighty":6.945611,"marketCap":4087141946},{"date":"2024-12-06","current":2.993073,"twenty":4.802241,"median":5.688534,"eighty":6.938687,"marketCap":3893987790},{"date":"2024-12-13","current":3.028705,"twenty":4.79641,"median":5.669359,"eighty":6.935901,"marketCap":3940344787},{"date":"2024-12-20","current":2.886177,"twenty":4.785493,"median":5.640128,"eighty":6.92838,"marketCap":3754916797},{"date":"2024-12-27","current":2.981196,"twenty":4.78255,"median":5.631097,"eighty":6.920174,"marketCap":3878535457},{"date":"2025-01-03","current":3.056418,"twenty":4.749673,"median":5.605846,"eighty":6.918788,"marketCap":3976400230},{"date":"2025-01-10","current":3.13758,"twenty":4.723888,"median":5.601495,"eighty":6.91493,"marketCap":4081991168},{"date":"2025-01-17","current":3.115805,"twenty":4.67721,"median":5.572999,"eighty":6.912589,"marketCap":4053661892},{"date":"2025-01-24","current":3.161334,"twenty":4.664146,"median":5.561865,"eighty":6.910087,"marketCap":4112895833},{"date":"2025-01-31","current":3.080173,"twenty":4.647848,"median":5.531664,"eighty":6.906277,"marketCap":4007304895},{"date":"2025-02-07","current":2.894096,"twenty":4.634673,"median":5.522398,"eighty":6.905243,"marketCap":3765218352},{"date":"2025-02-14","current":4.554623,"twenty":4.629584,"median":5.521496,"eighty":6.903522,"marketCap":3935194010},{"date":"2025-02-21","current":4.617219,"twenty":4.623979,"median":5.516224,"eighty":6.903079,"marketCap":3989277173},{"date":"2025-02-28","current":4.451431,"twenty":4.61924,"median":5.504727,"eighty":6.902723,"marketCap":3846036721},{"date":"2025-03-07","current":4.609665,"twenty":4.614238,"median":5.498877,"eighty":6.900767,"marketCap":3982750300},{"date":"2025-03-14","current":4.570853,"twenty":4.610485,"median":5.490042,"eighty":6.894732,"marketCap":3949216781},{"date":"2025-03-21","current":4.594737,"twenty":4.610485,"median":5.470653,"eighty":6.87898,"marketCap":3969852793},{"date":"2025-03-28","current":4.33201,"twenty":4.59497,"median":5.469038,"eighty":6.877461,"marketCap":3742856661},{"date":"2025-04-04","current":3.896122,"twenty":4.573766,"median":5.450406,"eighty":6.873684,"marketCap":3366249444},{"date":"2025-04-11","current":3.337827,"twenty":4.566004,"median":5.435812,"eighty":6.870939,"marketCap":2883882665},{"date":"2025-04-17","current":3.319914,"twenty":4.554623,"median":5.424537,"eighty":6.865469,"marketCap":2868405656},{"date":"2025-04-25","current":3.670676,"twenty":4.535517,"median":5.416979,"eighty":6.855496,"marketCap":3171463968},{"date":"2025-05-02","current":3.323972,"twenty":4.508029,"median":5.411689,"eighty":6.855496,"marketCap":2492978644},{"date":"2025-05-09","current":3.018956,"twenty":4.492912,"median":5.399053,"eighty":6.853351,"marketCap":2264217308},{"date":"2025-05-16","current":3.133337,"twenty":4.478301,"median":5.391629,"eighty":6.850782,"marketCap":2350002809},{"date":"2025-05-23","current":3.012024,"twenty":4.465548,"median":5.386922,"eighty":6.84266,"marketCap":2259018187},{"date":"2025-05-30","current":3.306641,"twenty":4.46155,"median":5.378621,"eighty":6.841761,"marketCap":2479980841},{"date":"2025-06-06","current":3.185328,"twenty":4.452729,"median":5.375659,"eighty":6.828932,"marketCap":2388996218},{"date":"2025-06-13","current":3.490343,"twenty":4.44498,"median":5.366934,"eighty":6.825771,"marketCap":2617757554},{"date":"2025-06-20","current":3.424488,"twenty":4.434814,"median":5.361182,"eighty":6.823019,"marketCap":2568365902},{"date":"2025-06-27","current":3.459149,"twenty":4.421651,"median":5.355424,"eighty":6.818667,"marketCap":2594361508},{"date":"2025-07-03","current":3.452217,"twenty":4.399361,"median":5.353312,"eighty":6.816041,"marketCap":2589162387},{"date":"2025-07-11","current":3.473013,"twenty":4.392883,"median":5.346145,"eighty":6.814026,"marketCap":2604759751},{"date":"2025-07-18","current":3.341302,"twenty":4.348402,"median":5.333952,"eighty":6.813112,"marketCap":2505976447},{"date":"2025-07-25","current":3.490343,"twenty":4.330906,"median":5.318366,"eighty":6.812157,"marketCap":2617757554},{"date":"2025-08-01","current":3.362098,"twenty":4.296183,"median":5.315957,"eighty":6.808736,"marketCap":2521573811},{"date":"2025-08-08","current":3.383266,"twenty":4.224538,"median":5.29108,"eighty":6.804749,"marketCap":2368286424},{"date":"2025-08-15","current":3.487253,"twenty":4.211972,"median":5.287079,"eighty":6.800478,"marketCap":2441076786},{"date":"2025-08-22","current":3.446401,"twenty":4.160392,"median":5.281596,"eighty":6.7962,"marketCap":2412480573},{"date":"2025-08-29","current":3.409263,"twenty":4.127087,"median":5.2736,"eighty":6.795204,"marketCap":2386484015},{"date":"2025-09-05","current":3.594953,"twenty":4.092863,"median":5.270811,"eighty":6.793019,"marketCap":2516466804},{"date":"2025-09-12","current":3.958904,"twenty":4.063086,"median":5.266553,"eighty":6.789744,"marketCap":2771233072},{"date":"2025-09-19","current":4.029466,"twenty":4.045602,"median":5.247806,"eighty":6.786941,"marketCap":2820626532}],"updateTime":1758570563432},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OGN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549531368","title":"Organon's VTAMA Cream Receives Strong Recommendation in Updated 2025 AAD Guidelines for Adult Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2549531368","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549531368?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:30","pubTimestamp":1751887820,"startTime":"0","endTime":"0","summary":"Organon & Co. has announced that their VTAMA  cream, 1%, has been granted a strong recommendation by the American Academy of Dermatology  in its 2025 guideline update for managing moderate to severe atopic dermatitis  in adults. This highlights VTAMA cream as a steroid-free, effective option for daily disease management without restrictions on use based on disease severity or body surface area. The FDA had previously approved VTAMA cream for the treatment of AD in adults and children aged 2 years and older, as well as for plaque psoriasis in adults. This strong recommendation from AAD is based on the cream's demonstrated efficacy, safety, and tolerability, as seen in clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDLbscWSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN","BK4588","BK4559","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","BK4585","BK4007","LU2065169927.USD"],"gpt_icon":0},{"id":"2548821830","title":"Karolinska Development Faces Impairment Following Organon's Discontinuation of OG-6219","url":"https://stock-news.laohu8.com/highlight/detail?id=2548821830","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548821830?lang=en_us&edition=fundamental","pubTime":"2025-07-03 13:00","pubTimestamp":1751518828,"startTime":"0","endTime":"0","summary":"STOCKHOLM, SWEDEN - July 3, 2025. Karolinska Development AB  has announced an update regarding an accounting issue related to the drug candidate OG-6219. Following Organon's decision to discontinue the clinical development of OG-6219, after disappointing Phase 2 study results, Karolinska Development recognizes the potential need for an impairment. The company had previously estimated the risk-adjusted net present value of future cash flows associated with earn-out payments from the project at SEK 76.2 million. A final impairment assessment will be presented in the interim report for the second quarter of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Karolinska Development AB published the original content used to generate this n","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nNDLLmq63:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2065170008.USD","BK4007","LU2065171311.SGD","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","BK4112","LU2210149790.SGD","BK4588","LU2065169927.USD","NDAQ","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2065171402.SGD","OGN","BK4559"],"gpt_icon":0},{"id":"2548107158","title":"Organon & Co. Files Initial Beneficial Ownership Statement for Director Ramona Sequeira","url":"https://stock-news.laohu8.com/highlight/detail?id=2548107158","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548107158?lang=en_us&edition=fundamental","pubTime":"2025-07-03 04:44","pubTimestamp":1751489061,"startTime":"0","endTime":"0","summary":"Organon & Co. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing mentions Ramona Sequeira as the beneficial owner, who serves as a Director at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL9Bgd99:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065169927.USD","BK4588","BK4559","LU2065171402.SGD","LU2065170008.USD","OGN","LU2065171311.SGD","BK4585"],"gpt_icon":0},{"id":"2548141158","title":"BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2548141158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548141158?lang=en_us&edition=fundamental","pubTime":"2025-07-03 02:00","pubTimestamp":1751479228,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos FinancialEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL6N3SZ0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GBX","FCX","STLD","OGN","ZVRA","PRMB","EQT","REGN","XOM","SPOT","ISTR","APA","SCCO","CNC","STZ","VRNT","NUE","ANF","GEV","CVNA","CVX","FSLR","OMDA","BMRC","CAVA","AX","ROST","DFDV","KBR","DNTH","ABM","JBL","ALV","MO","VFC","RIVN","ELV","ABEO","CARG","UAA","AVBP"],"gpt_icon":1},{"id":"2548897651","title":"BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier","url":"https://stock-news.laohu8.com/highlight/detail?id=2548897651","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548897651?lang=en_us&edition=fundamental","pubTime":"2025-07-02 21:10","pubTimestamp":1751461853,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, GreenbrierEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL6N3SZ0D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNC","DFDV","LU2324357040.USD","RIO.UK","LU0612318385.USD","LU0122376428.USD","JBL","LU0149725797.USD","AVBP","ZVRA","BK4507","LU0738911758.USD","IE00BQXX3D17.EUR","RIO.AU","OMDA","LU2290526834.HKD","LU2028103732.USD","LU2746668461.USD","LU2213496289.HKD","FCX","LU2125154935.USD","ROST","LU1084165304.USD","ABEO","ELV","LU2430703251.USD","MO","GBX","CVNA","OGN","APA","XOM","SPOT","LU1551013425.SGD","STZ","LU0823434740.USD","LU1267930227.SGD","EQT","ALV","LU2108987350.USD","LU1883866441.USD","BHP.AU","CAVA","SCCO","CVX"],"gpt_icon":1},{"id":"2548992748","title":"Organon to halt development of pelvic pain drug after mid-stage trial failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2548992748","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548992748?lang=en_us&edition=fundamental","pubTime":"2025-07-02 19:39","pubTimestamp":1751456350,"startTime":"0","endTime":"0","summary":"Organon to halt development of pelvic pain drug after mid-stage trial failureJuly 2  - Organon OGN.N said on Wednesday it will discontinue the development of its experimental pelvic pain drug after it failed to meet the main goal in a mid-stage study.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nL4N3SZ0RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","BK4585","OGN","BK4559","LU2065171311.SGD","LU2065169927.USD","BK4007","BK4588","LU2065170008.USD"],"gpt_icon":0},{"id":"2548899438","title":"Organon & Co. Discontinues Development of Endometriosis Drug After Phase 2 Study Fails Primary Efficacy Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2548899438","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548899438?lang=en_us&edition=fundamental","pubTime":"2025-07-02 19:30","pubTimestamp":1751455833,"startTime":"0","endTime":"0","summary":"Organon & Co., a global healthcare company specializing in women's health, has announced results from their Phase 2 ELENA proof-of-concept study. The study evaluated the investigational candidate OG-6219, an oral 17β-hydroxysteroid dehydrogenase type 1 inhibitor, in patients with endometriosis-related pain. The trial did not meet its primary efficacy endpoint, as OG-6219 failed to demonstrate improvement in moderate-to-severe endometriosis-related overall pelvic pain compared to placebo. Consequently, Organon plans to discontinue the clinical development program for OG-6219. The study was a randomized, double-blind, placebo-controlled, global multi-center trial involving pre-menopausal women aged 18 to 49 with surgically diagnosed endometriosis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL30ZWfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065171311.SGD","LU2065171402.SGD","BK4559","LU2065169927.USD","LU2065170008.USD","BK4588","OGN","BK4585"],"gpt_icon":0},{"id":"2548936358","title":"Shanghai Henlius Biotech Inc. Obtains EU GMP Certificates for HLX11 and HLX14 Production Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2548936358","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548936358?lang=en_us&edition=fundamental","pubTime":"2025-07-02 18:13","pubTimestamp":1751451224,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech Inc. has announced that its wholly-owned subsidiary, Shanghai Henlius Biologics Co., Ltd., has successfully obtained Certificates of GMP Compliance from the Federal Agency for Medicines and Health Products in Belgium. This certification applies to the drug substance and drug product lines for HLX11 and HLX14, indicating that these production lines meet the European Union's Good Manufacturing Practice standards. The approval facilitates the commercial production and distribution of HLX11 and HLX14 within the EU, bolstering the company's global pharmaceutical market presence. This development follows a previous exclusive licensing agreement with Organon LLC for the global commercialization of these products, excluding mainland China, Hong Kong, Macau, and Taiwan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL3dvSdz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK1230","LU2065171311.SGD","LU2065171402.SGD","BK1161","BK4559","LU2065169927.USD","BK4588","LU2065170008.USD","OGN","BK4585","00656","02696"],"gpt_icon":0},{"id":"2544297030","title":"Organon & Co. Faces Securities Class Action Lawsuit Over Dividend Misrepresentation; Shareholder Deadline Approaches","url":"https://stock-news.laohu8.com/highlight/detail?id=2544297030","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544297030?lang=en_us&edition=fundamental","pubTime":"2025-06-18 21:06","pubTimestamp":1750252016,"startTime":"0","endTime":"0","summary":"Organon & Co., a healthcare company based in Jersey City, NJ, is facing a securities class action lawsuit filed on behalf of investors who acquired the company's securities between October 31, 2024, and April 30, 2025. The lawsuit is in response to an unexpected change in the company's dividend payout policy following its acquisition of Dermavant for $1.2 billion. Despite assurances from Organon that the dividend would remain its top capital allocation priority, the company announced a reduction in its dividend from $0.28 to $0.02 per share on May 1, 2025, to focus on reducing debt. This news led to a significant decline in Organon's stock price, dropping approximately 27% to $9.45 per share. Investors who purchased Organon securities during the specified period have until July 22, 2025, to seek appointment as a lead plaintiff representative in the case. The litigation is being handled by Berger Montague PC, a firm known for its expertise in securities class action lawsuits.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDLbfqVg4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Organon & Co. Faces Securities Class Action Lawsuit Over Dividend Misrepresentation; Shareholder Deadline Approaches","news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2065170008.USD","LU2065171311.SGD","BK4559","LU2065171402.SGD","BK4007","OGN","BK4588","LU2065169927.USD"],"gpt_icon":0},{"id":"2543542751","title":"Organon & Co. Conducted Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543542751","media":"Reuters","labels":["executive","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543542751?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:21","pubTimestamp":1749759678,"startTime":"0","endTime":"0","summary":"Organon & Co. held its 2025 Annual Meeting on June 10, 2025. During the meeting, stockholders approved the election of eleven directors nominated by the Board. Additionally, an amendment and restatement of the Organon & Co. 2021 Incentive Stock Plan was approved, increasing the number of shares available for issuance by 7,800,000 and introducing a new requirement for a one-year minimum vesting period for 95% or more of shares subject to awards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL9jkPq1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4585","LU2065171402.SGD","BK4007","BK4588","LU2065171311.SGD","OGN","LU2065169927.USD","LU2065170008.USD"],"gpt_icon":0},{"id":"2543541535","title":"Securities Fraud Lawsuit Filed Against Organon & Co. Over Dividend and Debt Allocation Post-Dermavant Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2543541535","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543541535?lang=en_us&edition=fundamental","pubTime":"2025-06-13 02:00","pubTimestamp":1749751224,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Organon & Co., a healthcare company based in Jersey City, NJ, on behalf of investors who purchased Organon securities between October 31, 2024, and April 30, 2025. The lawsuit alleges that despite the company's assurances to maintain its dividend following its $1.2 billion acquisition of Dermavant, Organon shifted its capital allocation focus to debt reduction. Investors have until July 22, 2025, to seek appointment as lead plaintiff in the case. Berger Montague PC, a firm with a long history in securities litigation, is handling the case. Organon is noted for its focus on women's health and dermatological conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL8hQGVq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Securities Fraud Lawsuit Filed Against Organon & Co. Over Dividend and Debt Allocation Post-Dermavant Acquisition","news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065169927.USD","BK4559","BK4588","BK4585","LU2065170008.USD","BK4007","LU2065171311.SGD","OGN"],"gpt_icon":0},{"id":"2540718766","title":"Press Release: Shareholders who lost money on Organon & Co. (NYSE: OGN) Should Contact Wolf Haldenstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2540718766","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540718766?lang=en_us&edition=fundamental","pubTime":"2025-06-03 03:59","pubTimestamp":1748894340,"startTime":"0","endTime":"0","summary":"NEW YORK, June 2, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Organon & Co.  in the United States District Court for the District of New Jersey. Investors who acquired Organon shares during the class period are encouraged to contact the law firm before the lead plaintiff motion deadline on July 22, 2025.PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION. -- Class Period: October 31, 2024 -- April 30, 2025. -- Concealment of Material Information: Organon allegedly misrepresented its. priority, the company was internally shifting focus toward debt. -- Dividend Cut: Following the acquisition of Dermavant Sciences Ltd.,encouraged to contact the law firm of Wolf Haldenstein Adler & Herz LLP. Why Wolf Haldenstein Adler Freeman & Herz LLP?We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman &","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","NYSE","BK4588","BK4007","LU2065171402.SGD","OGN","BK4585","BK4559","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"2540790576","title":"Organon & Co. Faces Securities Fraud Lawsuit Over Alleged Misleading Capital Allocation Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2540790576","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540790576?lang=en_us&edition=fundamental","pubTime":"2025-06-03 02:16","pubTimestamp":1748888218,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Organon & Co. on behalf of investors who purchased the company's securities between October 31, 2024, and April 30, 2025. The lawsuit claims that Organon, following its $1.2 billion acquisition of Dermavant, assured investors that maintaining its dividend was its top capital allocation priority. However, it is alleged that the company shifted its focus to debt reduction instead. Investors have until July 22, 2025, to seek appointment as lead plaintiff in the case. Organon, headquartered in Jersey City, NJ, specializes in women's health.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via Newsfile  on Jun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL9y5ZXn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Organon & Co. Faces Securities Fraud Lawsuit Over Alleged Misleading Capital Allocation Priorities","news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4559","BK4007","BK4588","LU2065170008.USD","BK4585","OGN","LU2065171402.SGD","LU2065169927.USD"],"gpt_icon":0},{"id":"2538460575","title":"Organon, Samsung Bioepis Say FDA Grants Interchangeability Designation to Hadlima","url":"https://stock-news.laohu8.com/highlight/detail?id=2538460575","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538460575?lang=en_us&edition=fundamental","pubTime":"2025-05-27 22:51","pubTimestamp":1748357465,"startTime":"0","endTime":"0","summary":"Organon  and Samsung Bioepis said Tuesday that the US Food and Drug Administration has designated Hadlima high and low concentration autoinjectors and high-concentration prefilled syringe as interchangeable biosimilars to AbbVie's  Humira.The FDA previously granted interchangeability designation to Hadlima low-concentration prefilled syringe and single-dose vial in June 2024, the company said.An interchangeability designation enables a pharmacist to substitute the reference product with a biosimilar without the need to consult the prescriber, the company said.Shares of Organon were 5% higher in recent trading.Price: 9.11, Change: +0.42, Percent Change: +4.78","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2133065610.SGD","LU2468319806.SGD","BK4559","LU0310800379.SGD","SG9999001440.SGD","BK4566","LU0882574055.USD","LU0912757837.SGD","LU0310799852.SGD","BK4550","IE0002141913.USD","LU0170899867.USD","LU0861579265.USD","LU1496350502.SGD","OGN","LU1244550221.USD","LU1989772840.SGD","BK4007","LU0256863902.USD","LU1003077747.HKD","LU1989772923.USD","LU1929549753.HKD","LU1244550577.SGD","LU0122379950.USD","IE00B42XCP33.USD","IE00BJJMRZ35.SGD","IE00BGHQF631.EUR","LU2087621335.USD","LU0114720955.EUR","LU1057294990.SGD","LU2129689605.HKD","LU1934455194.USD","LU2237443978.SGD","LU1989771016.USD","LU1839511570.USD","BK4585","IE00BSNM7G36.USD","ABBV","LU1934455277.USD","LU1244550494.USD","IE00BVYPNW00.USD","LU0211328371.USD","IE0002270589.USD","LU2089284900.SGD","LU1093756325.SGD","SG9999015952.SGD","LU2089283258.USD","LU0211327993.USD","LU0417517546.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2537007924","title":"Organon & Co. Files Initial Beneficial Ownership Statement for Lynette Holzbaur, SVP and Corporate Controller","url":"https://stock-news.laohu8.com/highlight/detail?id=2537007924","media":"Reuters","labels":["executive","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537007924?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:06","pubTimestamp":1747944366,"startTime":"0","endTime":"0","summary":"Organon & Co. has filed an initial statement of beneficial ownership with the Securities and Exchange Commission. The statement lists Lynette Holzbaur as the beneficial owner in her capacity as the Senior Vice President and Corporate Controller. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL6Z2sRr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065169927.USD","BK4007","LU2065171311.SGD","BK4559","LU2065171402.SGD","OGN","LU2065170008.USD","BK4585"],"gpt_icon":0},{"id":"2535875639","title":"Organon & Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2535875639","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535875639?lang=en_us&edition=fundamental","pubTime":"2025-05-16 00:25","pubTimestamp":1747326300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2025 12:25 ET (16:25 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"gpt_icon":0},{"id":"2533137057","title":"BRIEF-EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2533137057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533137057?lang=en_us&edition=fundamental","pubTime":"2025-05-08 23:11","pubTimestamp":1746717083,"startTime":"0","endTime":"0","summary":"BRIEF-EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg TabletsMay 8  - EMA:EMA: CONFIRMED SUICIDAL IDEATION AS A SIDE EFFECT OF FINASTERIDE 1 AND 5 MG TABLETSEMA: PRAC AGREED THAT SUICIDAL IDEATION SHOULD BE INCLUDED AS A SIDE EFFECT OF FINASTERIDE TABLETSEMA: NOT POSSIBLE TO ESTABLISH A LINK BETWEEN SUICIDAL IDEATION AND DUTASTERIDEEMA: NO EVIDENCE LINKING SUICIDAL IDEATION TO FINASTERIDE SKIN SPRAYSFurther company coverage: OGN.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nFWN3RG4SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4585","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","OGN","BK4007","BK4588","LU2065169927.USD"],"gpt_icon":0},{"id":"2533135964","title":"EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2533135964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533135964?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:37","pubTimestamp":1746711436,"startTime":"0","endTime":"0","summary":"EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug May 8  - The European drugs regulator said on Thursday its safety committee has confirmed suicidal thoughts as a side effect of Organon's OGN.N anti hair-loss drug finasteride, following an EU-wide review of available data.    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL4N3RG1VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OGN","BK4559","BK4585","BK4588","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2533534502","title":"BUZZ-U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, Skechers","url":"https://stock-news.laohu8.com/highlight/detail?id=2533534502","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533534502?lang=en_us&edition=fundamental","pubTime":"2025-05-05 23:41","pubTimestamp":1746459710,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, SkechersEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL6N3RD0G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVN","SDST","PUMP","EXPE","CVX","APA","UAL","HWM","BTU","AU","SLB","ON","CNK","WBD","AAL.UK","TSN","NEM","ETN","PTEN","NOVA","CAPR","PARA","HHH","SUN","BCRX","FAAS","EPWK","NITO","EQT","OGE","AMC","SKX","OGN","XOM","WEN","PTCT","LUV","HAL","IART","CMI","HSIC"],"gpt_icon":1},{"id":"2532810474","title":"Evercore ISI Downgrades Organon to In Line From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2532810474","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532810474?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:45","pubTimestamp":1746186328,"startTime":"0","endTime":"0","summary":"Organon & Co (OGN) has an average rating of hold and mean price target of $18.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OGN"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}